Affordable GLP-1? When Digital Platforms Meet Policy Reform.
Where this comes from
- Record sourced from PubMed, PMID 42224006.
- Also identified by DOI 10.2196/102069 and PMC identifier 13224918.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent shifts in US policy and digital platforms are making obesity medications more affordable. In this News and Perspectives article, JMIR Correspondent Xiangming Jenny Zhan reports on this emerging access model and its potential implications.
Medical subject headings
- Glucagon-Like Peptide 1
- Health Policy